← Back to Search

Other

Muscle Cooling for Exercise Training

N/A
Waitlist Available
Led By Dustin R Slivka, PHD
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-hours post exercise
Awards & highlights

Study Summary

This trial will study how different temperatures affect human skeletal muscle during resistance exercise, in order to better understand how to stimulate growth responses.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-hours post exercise
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-hours post exercise for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
RT-qPCR for Forkhead Box O3 (FOXO3a)
RT-qPCR for Growth/Differentiation Factor 8 (MSTN)
RT-qPCR for Myocyte Enhancer Factor 2A (MEF2a)
+7 more
Secondary outcome measures
Muscle Temperature
Skin Temperature

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Muscle CoolingExperimental Treatment2 Interventions
The intervention will be applying a cooling wrap during the bilateral resistance exercise.
Group II: ControlPlacebo Group1 Intervention
There will be no temperature alteration for this leg during bilateral resistance exercise.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Muscle Cooling
2022
N/A
~20

Find a Location

Who is running the clinical trial?

University of NebraskaLead Sponsor
539 Previous Clinical Trials
1,144,722 Total Patients Enrolled
1 Trials studying Exercise Training
2 Patients Enrolled for Exercise Training
Dustin R Slivka, PHDPrincipal InvestigatorUniversity of Nebraska
2 Previous Clinical Trials
24 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025